The FDA plans to hold an advisory committee meeting to discuss Capricor Therapeutics’ application for deramiocel, which the agency rejected last July. The news surprised CEO Linda Marbán, who told ...

Jubilant HollisterStier received a warning letter over problems that the FDA said necessitate an immediate and comprehensive ...

After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing ...

Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to ...

Sanofi makes no mention of the Commissioner’s National Priority Voucher. Tzield was awarded the ticket in October 2025, but ...

Following the mid-stage readout, Verastem Oncology has decided to move away from its investigational pancreatic cancer drug ...

Denali Therapeutics is the latest company to sell a priority review fast pass for an elevated price after the program was ...

Body scans additionally showed that Imcivree’s effects were driven largely by a reduction in fat rather than muscle. Fat mass ...

Ibogaine’s unconventional “matrix pharmacology” may underlie both its therapeutic promise and unpredictable cardiac risks.

Intellia Therapeutics's Senior Vice President Maria Natale discusses why the most successful launches are shaped long before ...

Even something as simple as “Tell me about yourself” can trip up biopharma professionals during job interviews. Two ...

While biopharma’s overarching mission is to develop innovative medicines to improve patient outcomes, for these six people, ...